ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

1,2-ビス(クロロメトキシ)エタン

1,2-Bis(CHLOROMETHOXY)ETHANE

HCID 61632
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
13483-18-6
標準SMILES
ClCOCCOCCl
InChIKey
IDFLGSYEBJNWMK-UHFFFAOYSA-N
分子式
C4H8Cl2O2
平均分子量
159.01 g/mol
単同位体質量
157.9901349

概要

1,2-Bis(chloromethoxy)ethane is an ether.

名称と識別子

優先名称
1,2-Bis(CHLOROMETHOXY)ETHANE
IUPAC
1,2-bis(chloromethoxy)ethane
現地名
1,2-ビス(クロロメトキシ)エタン
英語名
1,2-bis(chloromethoxy)ethane
分子式
C4H8Cl2O2
分子量
159.01

名称と別名

1,2-Bis(chloromethoxy)ethane13483-18-6Bis-1,2-(chloromethoxy)ethaneEthane, 1,2-bis(chloromethoxy)-Ethylene glycol bis(chloromethyl) etherEthylene glycol bis(chloromethyl)etherNSC 508881BRN 173572764W2G7H6SANSC-508881DTXSID3020170RefChem:71727
名称をさらに表示
エチレングリコールビス(クロロメチル)エーテル1,2-ビス(クロロメトキシ)エタン1,2ビス(クロロメトキシ)エタンGlycerol Impurity 4Erythromycin Impurity 26BIS-1,2(CHLOROMETHOXY)ETHANE1,2-bis(ChloroMethoxy)ethane (90%)
DTXCID50170236-791-61,2-bis(Chloromethoxy)ethane (>90%)CCRIS 1870HSDB 7105EINECS 236-791-6Ethylene glycol bis(chloromethyl) ether; NSC 508881UNII-64W2G7H6SA

データベース識別子

CAS
13483-18-6
PubChem CID
61632
DTXSID
DTXSID3020170
ChEBI
CHEBI:82407
UNII
64W2G7H6SA
EC Number

物性

構造計算による物性

XLogP
1.3
極性表面積
18.5 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
5
重原子数
8
形式電荷
0
複雑度
37

実験および物理化学的性質

Chemical ClassesOther Classes -> Other Organic Compounds
Density1.2879 @ 14 deg/15 °C
Color/FormViscous liquid
SolubilitySoluble in water
Boiling Point99-100 °C @ 22 mm Hg
DecompositionWhen heated to decompositionit emits toxic fumes of /hydrogen chloride/
Physical DescriptionLiquid; [HSDB]

物理化学的性質

沸点
221.93 °C · 221.93°C (rough estimate)
比重(密度)
1.3421 · 1.3421 (rough estimate)
屈折率
1.4386 · 1.4386 (estimate)
貯蔵温度
-20 °C · -20°C Freezer, Under inert atmosphere
溶解性
クロロホルム(微量)、ジクロロメタン(微量)、メタノール(微量)
外見
油
色
粘性液体

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全と保護具

Disposal Methods · 1 件

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

毒性情報

Carcinogen Classification · 5 件

1,2-Bis(chloromethoxy)ethane

Group 3: Not classifiable as to its carcinogenicity to humans

Volume 15: (1977) Some Fumigants, the Herbicides 2,4-D and 2,4,5-T, Chlorinated Dibenzodioxins and Miscellaneous Industrial Chemicals

1999

1998

Non-Human Toxicity Excerpts · 3 件

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Fifty 6-8 wk old female ICR/Ha Swiss mice were administered 1 mg 1,2-bis(chloromethoxy)ethane in 0.1 ml cyclohexane on the dorsal skin thrice weekly for up to 502 days, at which time more than half the animals were still alive. Four mice developed skin papillomas, the first of which appeared after 320 days, and 4 animals had local squamous-cell carcinomas (p<0.05). In 50 control mice treated with cyclohexane only, the median survival time was >504 days; no tumors occurred at the site of administration.

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Fifty 6-8 wk old female ICR/Ha Swiss mice were given weekly sc injections of 0.3 mg 1,2-bis(chloromethoxy)ethane in 0.05 ml tricaprylin. The test lasted 569 days, and the median survival time of treated mice was 362 days. Nine mice had local sarcomas (p<0.01). In 50 control animals treated with tricaprylin alone, the median survival time was 436 days; no local malignant tumors occurred.

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Thirty 6-8 wk old female ICR/Ha Swiss mice were given weekly ip injections of 0.3 mg 1,2-bis(chloromethoxy)ethane in 0.05 ml tricaprylin. The test lasted 546 days, and the median survival time of treated mice was 481 days. Two mice developed undifferentiated malignant tumors at the injection site, and 2 had local sarcomas (p<0.05). In 30 controls treated with tricaprylin alone, the median survival time was 513 days; no local malignant tumors occurred.

化学と産業

用途と製造

Uses · 3 件

A research chemical that has been tested for use in textiles (wrinkle-resistance and dyeing), rubber (stabilizer),epoxy resins (curing agent), lithographic plates (light-sensitive polymers), and ion exchange resins; [HSDB]

Plastic Composites Manufacturing [Category: Industry]

Although 1,2-bis(chloromethoxy)ethane does not appear to have been used commercially, it has been investigated for potential commercial use on cellulosic textiles for imparting crease resistance; improving wet strength and facilitating dyeing; as a stabilizer for vulcanized rubbers; as a curing agent for epoxy resins; in the preparation of light-sensitive polymers for lithographic plates; and in the synthesis of ion-exchange resins.

General Manufacturing InformationEthane, 1,2-bis(chloromethoxy)-: INACTIVE

応用分野

使用1,2-bis(Chloromethoxy)ethane is a carcinogenic compound.

サプライヤー15 社

济南百隆化学有限公司[email protected] · [email protected]
陕西缔都新材料有限公司029-63373950 17392216152 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海创焰化学科技有限公司021-11111111 11111111111 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
236-791-6
Nikkaji
J34.807D
安定性
湿気に敏感
EPAの化学物質情報
1 · Ethane, 1,2-bis(chloromethoxy)- (13483-18-6)

化学的性質

化学的特性Viscous liquid.

Evidence for Carcinogenicity · 1 件

Evaluation: No epidemiological data relevant to the carcinogenicity of 1,2-bis(chloromethoxy)ethane were available. There is limited evidence in experimental animals for the carcinogenicity of 1,2-bis(chloromethoxy)ethane. Overall Evaluation: 1,2-Bis(chloromethoxy)ethane is not classifiable as to its carcinogenicity to humans (Group 3).

Antidote and Emergency Treatment · 2 件

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in respiratory arrest. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Watch for signs of fluid overload. Consider drug therapy for pulmonary edema ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam (Valium) ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poison A and B/

安全データ

tsca
TSCA listed
有毒物質データの
13483-18-6(Hazardous Substances Data)
400-0056266 · [email protected]
Standardpharm Co. Ltd.86-714-3992388 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
Xuzhou B&C Chemical Technology Co., Ltd+86-400-0516-021 +86-15190678838 · [email protected]
嘉兴市德亿化工有限公司86-0573-85866609 18367600069 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
徐州博康化学科技股份有限公司051686297676 · [email protected]